Latest BioPharma News and In-Depth Analysis | BioPharma BoardRoom

10 April, 2026 | Friday

GDMC Charts a New Course in Genetic Therapy Innovation with Strategic Series A Investment

In an interview with BioPharma BoardRoom, Eric Blair, GDMC’s Chief Business Officer, discusses the company's strategic use of Series A funding to pio...

February 14, 2024 | Wednesday | Interview

Examining the Biopharma Industry's Declining Resilience: Factors, Vulnerabilities, and Strategies for Growth

Join us for an in-depth conversation with Chua Keng Hock as we explore the challenges, strategies, and future prospects of the biopharma industry in today'...

July 18, 2023 | Tuesday | Interaction

1
2
3

Partner Content

BioPharma BreakThrough's

HUTCHMED Expands Hematology Pipeline with Phase III Start for HMPL-760
24 March, 2026
Imaginostics Secures Siemens Healthineers Support for Quantitative MRI Collaboration
24 March, 2026
Curi Bio, Battelle Join Forces to Accelerate Adoption of Human-Relevant NMJ Assays
24 March, 2026
Bristol Myers Squibb Advances Immuno-Oncology Footprint with New Opdivo Indications
24 March, 2026
Oryon Reports Sustained Motor Improvement with Autologous Neuron Therapy in Parkinson’s
24 March, 2026
Congruence Therapeutics Doses First Patient in Phase 1/1b Trial of MC4R Corrector CGX-926 for Genetic Obesity
23 March, 2026

Editor Picks

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

Gene Editing Breakthroughs

Innovative Drug Discovery

Vaccine Development

Biologics and Therapeutic Antibodies

× Please select an option to participate in the poll.

View poll results More polls

× You have successfully cast your vote.

{{ optionDetail.option }} {{ optionDetail.percentage }}%

More polls

About Us Media Pack Contact Us Privacy Policy

© 2026 Biopharma Boardroom. All Rights Reserved.